NCT07480109 Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity)
| NCT ID | NCT07480109 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Texas at Austin |
| Condition | Obesity |
| Study Type | INTERVENTIONAL |
| Enrollment | 75 participants |
| Start Date | 2026-06-01 |
| Primary Completion | 2027-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 75 participants in total. It began in 2026-06-01 with a primary completion date of 2027-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Middle-aged women with (overweight/)obesity who will begin or have begun GLP-1 medication use will be recruited to complete a 12-week diet intervention study. For 12-weeks, participants will continue to take their GLP-1 medication and may be provided with protein-rich foods to consume every day. Body composition, eating behavior, health, and well-being will be measured before and after the study.
Eligibility Criteria
Inclusion Criteria: * Adult women (30-60 years) * Having overweight or obesity (BMI \>25 kg/m2) * Prescribed or taking GLP-1 medicine (within 4 weeks) by a physician * Willing and able to maintain current inactivity patterns throughout the study * Willing and able to follow all study procedures * Generally healthy, as assessed from the medical history questionnaire Exclusion Criteria: * Adults (\<30 years or \>60 years) * Having normal weight (BMI \<25 kg/m2) * Not prescribed GLP-1 medication by a physician * Those on GLP-1 medication longer than 4 weeks (during time of screening) * Currently on a high-protein or other specific diet * Unwilling and/or unable to maintain current inactivity patterns throughout the study * Unwilling and/or unable to follow all study procedures * Unwilling and/or unable to eat pork (for the GLP-1 + Protein group) * Not generally healthy, as assessed from the medical history questionnaire
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07480109 clinical trial?
This trial is open to female participants only, aged 30 Years or older, up to 60 Years, studying Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07480109 currently recruiting?
Yes, NCT07480109 is actively recruiting participants. Contact the research team at Heather.Leidy@austin.utexas.edu for enrollment information.
Where is the NCT07480109 trial being conducted?
This trial is being conducted at Austin, United States, Austin, United States.
Who is sponsoring the NCT07480109 clinical trial?
NCT07480109 is sponsored by University of Texas at Austin. The trial plans to enroll 75 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.